News

	Feb22	Lab21 and IntegraGen partner to develop new colorectal cancer diagnostic 22/02/2013

	Jan8	Lab21 Announces Sale of South Carolina Operations 08/01/2013

	Oct15	BD and Lab21 Collaborate to Develop New Oncology Assays on the BD MAX™ Platform 15/10/2012

	Jul12	Lab21 among first to offer FDA approved Companion Diagnostic in the US 12/07/2012

	Jul9	CLYDESDALE BANK £5 MILLION FUNDING TO SUPPORT LAB21 INTERNATIONAL GROWTH 09/07/2012

	Jun26	Lab21 partners with major pharmaceutical company to develop new companion diagnostic 26/06/2012

	May15	Lab21 secures European and USA patents for HCV drug resistance genotyping 15/05/2012

	May11	Lab21 unveils new molecular analysis services at Greenville site 11/05/2012

	Apr10	Lab21 partners with top 10 IVD player to develop new Aspergillus molecular assay 10/04/2012

	Mar6	Lab21 and ITOR launch Clinical Genomics Center in USA 06/03/2012

	Feb20	Lab21 announces appointment of industry expert Fraser Logue 20/02/2012

	Feb16	Lab21 launches new lung cancer Companion Diagnostic service 16/02/2012

	Jan23	Lab21 Acquires new real time PCR technology 23/01/2012

	Dec13	Lab21 receives regulatory approval for Campylobacter assay in China 13/12/2011

	Nov29	Lab21 Ranked in Fastest Growing Technology Companies on the Deloitte Fast 500 EMEA 2011 29/11/2011

	Nov29	Lab21 Wins Biomedical Project of the Year Award 29/11/2011

	Nov9	Lab21 announces positive results for Aspergillus detection in critical care and haematology patients 09/11/2011

	Oct27	Lab21 extends CPA accreditation 27/10/2011

	Sep28	QIPP 3rd Annual Symposium: Improving Outcomes Through Innovative Partnerships 28/09/2011

	Aug5	Lab21 Contributes to Human Genetics Commission Report on Diagnostic Testing 05/08/2011

	Aug3	BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System 03/08/2011

	May23	Lab21 acquires molecular diagnostics company Myconostica Ltd 23/05/2011

	Jan6	Lab21 acquires Microgen Bioproducts 06/01/2011